Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Playfair Capital is an active London-based venture capital firm specializing in pre-seed investments across sectors including AI, SaaS, healthtech, fintech, and more. It invests in about six to eight companies per year with high conviction and provides operational as well as strategic support. The fund has backed over 100 companies since its founding in 2013 and recently closed its third fund at $70 million[1][2][3][4].
While sector agnostic, Playfair has invested in several healthtech and wellness startups but does not focus exclusively on life sciences or healthcare.
The team emphasizes diversity (notably through Female Founder Office Hours) and long-term founder relationships. Its portfolio includes notable tech companies such as Thought Machine, Andela, Mapillary (acquired by Facebook), Omnipresent, Protex AI, Orca AI, Recycleye among others[1][5].
Key people include Managing Partner Chris Smith and Founding Partner Federico Pirzio-Biroli.
Playfair typically invests £750k per deal with historical checks ranging from $1M to $23M. About 73% of their portfolio companies have gone on to raise Series A rounds[1].
The firm's main geographic focus is the UK and Europe.
It does not develop drugs/devices itself nor operate clinical programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Playfair Capital.